Charcot-Marie-Tooth Disease Type 1 Caused by Mutation in LITAF

Charcot-Marie-Tooth disease type 1 caused by mutation in LITAF is usually called Charcot-Marie-Tooth disease type 1C (CMT1C). It is a rare, inherited nerve disease. It mainly damages the long nerves in the arms and legs. These nerves carry signals to muscles (motor) and from the skin (sensory). So both movement and feeling can slowly become weaker.National Organization for Rare Disorders+1

Charcot-Marie-Tooth disease type 1 (CMT1) is a group of inherited disorders that slowly damage the peripheral nerves, which are the long nerves that carry signals to and from the arms and legs. In one rare form, called CMT1C, the problem is a harmful change (mutation) in a gene called LITAF, which is important for the health of myelin, the insulation layer around nerves. When LITAF does not work properly, the myelin becomes thin and damaged, so nerve signals travel slowly and weakly, causing muscle weakness, loss of feeling, foot deformities, and problems with balance and walking. There is no cure yet, but treatments can improve strength, comfort, and everyday function and help prevent complications over time. ScienceDirect+5PMC+5

CMT1C belongs to the demyelinating group of CMT type 1 disorders. “Demyelinating” means the myelin coating around the nerve fibers is damaged. Myelin works like insulation on electric wires. When it is damaged, nerve signals travel more slowly and can be blocked. This causes weakness, loss of feeling, and typical foot deformities.NCBI+1

The cause of CMT1C is a change (mutation) in the LITAF gene. LITAF stands for “lipopolysaccharide-induced tumor necrosis factor factor.” This gene also has the protein name SIMPLE. The faulty LITAF protein does not work normally inside nerve support cells called Schwann cells. This leads to myelin damage and a slowly progressive, often mild, inherited neuropathy.PLOS+1

CMT1C is usually autosomal dominant. This means a person needs only one copy of the changed gene to have the disease. Most people show symptoms in childhood or early adult life, but many have mild problems and can stay active for many years.PubMed+1

---

Another names and types

CMT1C and LITAF-related neuropathy are known by several other names. Using these different names in an article helps search engines and also helps patients find information:National Organization for Rare Disorders+1

• Charcot-Marie-Tooth disease type 1C

• CMT1C

• Charcot-Marie-Tooth disease, demyelinating, type 1C

• LITAF-related Charcot-Marie-Tooth disease

• LITAF / SIMPLE-associated CMT

• CMT slow nerve conduction type C

Doctors also describe “types” of CMT1C based on how it looks in the clinic, not different diseases:SciSpace+1

• By age of onset

  • Childhood-onset CMT1C – symptoms start in school age with clumsiness, weakness, or foot deformity.

  • Adult-onset CMT1C – symptoms start later, often in the 20s–40s, and may be very mild.

• By severity

  • Mild CMT1C – most common; people can walk normally for many years, with only subtle weakness or high arches.

  • Moderate CMT1C – more obvious weakness, tripping, and hand problems later.

  • More severe CMT1C – uncommon; stronger weakness, but still usually less severe than CMT1A.

• By specific LITAF mutation
  Doctors can group patients by the exact DNA change in LITAF (for example, G112S, T49M, R160H and others). Different mutations can cause slightly different ages of onset and levels of disability, but all share the same basic pattern of a slowly progressive demyelinating neuropathy.PubMed+2PMC+2

---

Causes

Remember: the core cause of CMT1C is a pathogenic mutation in the LITAF gene. The list below breaks this into 20 simple “cause and contributor” points to explain what is happening in the body and what can make the condition worse.

1. Pathogenic LITAF gene mutation
   The main cause is a harmful change in the LITAF gene. This change alters the instructions for making the LITAF (SIMPLE) protein. Because this protein is important in Schwann cells, the cells cannot handle myelin and membrane proteins correctly, leading to nerve damage and CMT1C.American Academy of Neurology+1

2. Abnormal LITAF protein structure
   Many LITAF mutations are missense changes, which swap one amino acid for another. This small change can bend or twist the protein in the wrong way, so it can no longer do its normal job inside the cell. Mis-shaped LITAF proteins are a direct structural cause of disease.PLOS+1

3. Mislocalization of LITAF inside the cell
   Normal LITAF sits in endosomes and lysosomes (small bags inside the cell that handle membrane recycling and waste). In CMT1C, mutant LITAF is often misplaced to the wrong part of the cell. This mislocalization disturbs traffic of myelin proteins and contributes to myelin injury.PLOS+1

4. Disrupted endosomal–lysosomal pathway
   LITAF helps control how some proteins are sorted and broken down. When LITAF is faulty, the endosomal–lysosomal pathway becomes abnormal. Waste and misfolded proteins can accumulate. This stresses Schwann cells and slowly damages myelin around peripheral nerves.molbiolcell.org+1

5. Protein degradation problems
   Some LITAF mutations cause the protein to be unstable and quickly destroyed by the cell’s “garbage disposal” systems (proteasome and autophagy). The lack of functional LITAF protein is another direct cause of Schwann cell dysfunction and demyelinating neuropathy.PLOS+1

6. Schwann cell myelin damage
   Schwann cells wrap myelin around nerve fibers. When their internal protein-handling system is disturbed by LITAF mutations, they cannot maintain healthy myelin. The myelin layer becomes thin, irregular, or breaks down, which is the hallmark of CMT1C.SciSpace+1

7. Demyelination of peripheral nerves
   Because of Schwann cell problems, myelin is lost (demyelination). Without enough myelin, electrical signals move much more slowly along nerves. Nerve conduction studies in CMT1C show slowed velocities and sometimes conduction block, confirming demyelination as a core cause of symptoms.SciSpace+1

8. Secondary axonal injury
   Long-lasting demyelination can strain the underlying axon (the main nerve fiber). Over time, this can lead to axonal loss. Losing axons reduces the number of working nerve fibers, causing more weakness and sensory loss in later stages of the disease.NCBI+1

9. Autosomal dominant inheritance
   The pattern of inheritance is autosomal dominant, so each child of an affected parent has about a 50% chance of receiving the mutation. This genetic transmission is a major “cause” of CMT1C in families. Many families show affected people in several generations.Wiley Online Library+1

10. De novo (new) mutations
    Sometimes, the LITAF mutation is not inherited but appears for the first time in a person because of a spontaneous DNA change. That person can then pass the mutation on to their children. These de novo events are a cause in families with no prior history.PMC+1

11. Specific high-risk LITAF variants
    Certain LITAF mutations (for example, G112S or R160H) have been clearly linked with CMT1C in several families. These specific variants are well-documented causes and have been studied in detail in clinical and lab research.PubMed+1

12. Genetic background and modifier genes
    People may carry other subtle gene changes that do not cause disease alone but can modify severity. In someone with a LITAF mutation, these “modifier genes” may influence how early symptoms appear or how fast they progress.Wiley Online Library+1

13. Age-related myelin vulnerability
    As nerves and myelin naturally age, they become more vulnerable to damage. In someone who already has a LITAF mutation, this normal aging process can reveal or worsen neuropathy, so age acts as a contributing cause of symptom progression.NCBI+1

14. Mechanical stress on nerves
    Repeated ankle sprains, tight shoes, or pressure on nerves may not cause CMT1C by themselves, but they can worsen weakness, pain, or deformities in someone whose nerves are already fragile because of LITAF-related demyelination.Patient+1

15. Metabolic stress such as diabetes
    Diabetes is a common cause of acquired neuropathy. In a person with CMT1C, uncontrolled diabetes can add extra nerve damage on top of inherited neuropathy. This can make symptoms more severe and appear earlier than expected for their genetic type.Patient+1

16. Nutritional deficiencies (for example vitamin B12)
    Lack of certain vitamins, especially vitamin B12, can also injure nerves. In a person with CMT1C, nutritional deficiency does not create the disease but can worsen the neuropathy. Treating the deficiency may improve overall nerve health, though it does not remove the genetic cause.Patient+1

17. Neurotoxic medications
    Some medicines, such as the chemotherapy drug vincristine, are known to be toxic to peripheral nerves. In people with any CMT, including CMT1C, these drugs can sharply worsen neuropathy. That is why guidelines advise avoiding such agents if possible.Patient+1

18. Excess alcohol use
    Long-term heavy alcohol use can cause a separate neuropathy. In a person with LITAF-related CMT, alcohol can add more nerve damage and lead to greater weakness and numbness than expected from the gene mutation alone.Patient+1

19. Inflammatory or immune stress on nerves
    Some reports suggest that CMT1C can sometimes be confused with inflammatory demyelinating neuropathies. Infections or immune activation may temporarily worsen nerve function, revealing underlying genetic CMT1C or adding extra damage.Charcot-Marie-Tooth News+1

20. Delayed diagnosis and lack of supportive care
    CMT1C progresses slowly, but untreated foot deformities, poor footwear, and lack of physical therapy can indirectly worsen disability. These are not genetic causes, but they are important contributors to how much the disease affects daily life.NCBI+1

---

Symptoms

Symptoms in CMT1C are very similar to other demyelinating CMT type 1 forms, but on average they are often mild to moderate. They usually start in the feet and legs and may later affect the hands.PubMed+2NCBI+2

1. Slowly increasing weakness in feet and ankles
   The first sign is often trouble lifting the front of the foot when walking. This happens because the small muscles that lift the foot become weak. People may say their feet feel heavy or that they cannot walk as fast as before.

2. Foot drop and high-stepping gait
   Because the front of the foot does not lift well, the toes can catch on the ground. To avoid tripping, the person lifts the knees higher than normal when walking. This is called a “steppage” or high-stepping gait.NCBI+1

3. High-arched feet (pes cavus)
   Over time, the imbalance between weak and relatively stronger muscles pulls the foot into a high-arched shape. The arch becomes very high, and the toes may curl. This foot deformity is a classic sign of CMT.Orthobullets+1

4. Curled toes (hammertoes)
   The small muscles inside the foot weaken, and the stronger outer muscles pull the toes into a bent position. Toes may rub against shoes and cause pain or calluses. Hammertoes often appear together with high arches.Orthobullets+1

5. Wasting of lower leg muscles (“inverted champagne bottle” legs)
   Because the muscles on the front and sides of the lower legs are not used properly, they shrink (atrophy). The legs can look thin below the knee while the thighs stay normal, giving the classic “inverted champagne bottle” shape.Orthobullets+1

6. Frequent tripping and falls
   Weak feet, foot drop, and poor balance make tripping and turning the ankle quite common. People may report many sprains or falls, especially on uneven ground or when walking in the dark.Patient+1

7. Difficulty running and sports
   Running needs fast, strong muscle contractions and good ankle control. Children with CMT1C may be slower than classmates in games or sports. Adults may notice they cannot run, jump, or climb stairs as easily as before.Wiley Online Library+1

8. Numbness or reduced feeling in feet and legs
   Sensory fibers are also affected. People often feel numbness, tingling, or a “cotton wool” feeling under the feet. They may not feel small injuries, heat, or cold as clearly, which can raise the risk of unnoticed wounds.NCBI+1

9. Loss of vibration and joint position sense
   Many people cannot feel a tuning fork vibration on the ankles or cannot tell the position of their toes with eyes closed. This loss of proprioception (position sense) makes balance harder, especially in the dark or with eyes closed.PFM Journal+1

10. Reduced or absent ankle reflexes
    When the doctor taps the Achilles tendon, the normal jerk may be weak or absent. This loss of tendon reflexes is typical in demyelinating CMT and helps in diagnosis.NCBI+1

11. Balance problems and unsteady walking
    Weakness, numbness, and poor position sense together cause unsteady gait. People may sway when they stand still, especially with their eyes closed (positive Romberg sign). They may avoid walking on uneven surfaces.NCBI+1

12. Pain or discomfort in feet and legs
    Some patients have aching pain in the feet or ankles from deformity, joint strain, or muscle fatigue. Others have burning, shooting, or electric-like pains due to nerve damage (neuropathic pain). The level of pain is very variable.Patient+1

13. Weakness in hands and fingers (later)
    In many people, weakness climbs slowly up the legs and then involves the hands. They may struggle with buttons, zippers, writing, or opening jars. Hand wasting is usually milder and appears after the leg symptoms.NCBI+1

14. Hand numbness and clumsiness
    Sensory changes can also affect the hands. People may drop objects or feel clumsy because they cannot fully sense grip strength or small object position. This tends to occur in more advanced disease.ScienceDirect+1

15. Fatigue and reduced endurance
    Because muscles are weak and nerves are inefficient, a simple activity can feel tiring. People may need more rest breaks when walking or doing daily tasks. Fatigue can also be emotional, as living with a chronic condition is stressful.NCBI+1

---

Diagnostic tests

Doctors use a combination of clinical examination, electrodiagnostic tests, and genetic testing to confirm CMT1C. Other tests help to exclude different causes of neuropathy. Below, tests are grouped into physical exam, manual tests, lab and pathological studies, electrodiagnostic tests, and imaging.PMC+2www.elsevier.com+2

Physical exam tests

1. Full neurological examination
   The doctor checks muscle strength, reflexes, and sensation in the arms and legs. In CMT1C, they often find distal (far from the body) weakness in feet and hands, loss of ankle reflexes, and reduced vibration and light touch in a “stocking and glove” pattern. This clinical picture raises suspicion for inherited neuropathy.NCBI+1

2. Gait observation
   The doctor watches the person walk, turn, and sometimes run. They look for a high-stepping gait, foot drop, and unsteadiness. Careful gait analysis helps separate CMT from joint diseases or brain disorders and guides which further tests are needed.NCBI+1

3. Foot and leg inspection
   The doctor examines the shape of the feet and legs. High arches, hammertoes, calluses, thin calves, and ankle instability are typical in CMT. Noting these structural changes supports a diagnosis of chronic neuropathy rather than a sudden or acute problem.Orthobullets+1

4. Romberg test (standing with eyes closed)
   The person stands with feet together and then closes their eyes. If they sway a lot or almost fall, the test is positive and suggests impaired position sense in the legs. This is common in length-dependent sensory neuropathies like CMT.PFM Journal+1

5. Proximal strength and cranial nerve exam
   The doctor checks muscles close to the body (hips, shoulders) and the cranial nerves (face, speech, swallowing, eye movements). In CMT1C these are usually normal, which helps rule out conditions like motor neuron disease or brainstem disorders.NCBI+1

Manual (bedside) tests

6. Manual muscle testing (MRC scale)
   The doctor asks the person to move each major muscle group against resistance and grades strength on a 0–5 scale. This detailed map shows which muscles are weak and how severe the weakness is. In CMT1C, weakness is usually distal and symmetric.PFM Journal+1

7. Heel-walking and toe-walking test
   The person walks on heels and then on toes. Weakness of the muscles that lift the foot makes heel-walking hard; weakness in calf muscles makes toe-walking difficult. This simple test helps reveal subtle foot drop or calf weakness.Patient+1

8. Tuning fork vibration test
   A vibrating tuning fork is placed on the big toe, ankle, and knee. The patient says when they stop feeling the vibration. In CMT1C, vibration sense is often lost at the toes and ankles, showing large-fiber sensory nerve involvement.Muscular Dystrophy Association+1

9. Light touch and pinprick mapping
   The doctor gently touches or uses a pinprick on the skin in a pattern from toes upward. Reduced sensation in a stocking distribution supports a peripheral neuropathy. Normal sensation would suggest another cause of weakness.NCBI+1

10. Balance and coordination tasks
    Tasks like standing on one leg, tandem walking (heel-to-toe), or reaching with eyes closed can show how neuropathy affects coordination. Difficulty mainly from loss of position sense points toward a peripheral nerve cause like CMT.Wiley Online Library+1

Lab and pathological tests

11. Basic blood tests to rule out acquired neuropathies
    Doctors usually order tests such as blood sugar, vitamin B12, thyroid function, kidney and liver function, and sometimes autoimmune markers. Normal results support an inherited neuropathy like CMT1C, while abnormal results may point to other or additional causes.Wiley Online Library+1

12. Serum protein electrophoresis
    This blood test looks for abnormal proteins produced by some blood cancers or immune conditions that can cause neuropathy. A normal test helps rule out a treatable paraproteinemic neuropathy and keeps attention on inherited causes.PMC+1

13. CMT gene panel testing
    Modern labs can test many neuropathy genes at once with next-generation sequencing panels. LITAF is included in many hereditary motor and sensory neuropathy panels. This approach is useful when the exact type of CMT is not yet clear.Mayo Clinic Laboratories+1

14. Targeted LITAF gene sequencing
    If clinical signs and nerve conduction studies suggest CMT1 and common causes like PMP22 duplication are negative, doctors can request focused sequencing of LITAF. Finding a clearly pathogenic mutation confirms CMT1C as the specific diagnosis.SciSpace+2National Organization for Rare Disorders+2

15. Nerve biopsy (now rarely needed)
    In the past, doctors sometimes took a small sample of a sensory nerve to look under the microscope. They might see demyelination and special structures called “onion bulbs.” Today, because genetic testing is widely available, nerve biopsy is used far less often and reserved for unclear cases.rjme.ro+1

Electrodiagnostic tests

16. Nerve conduction studies (NCS)
    This key test sends small electrical signals along nerves and records how fast and how strongly they respond. In CMT1C, there is slowing of motor and sensory conduction velocities, consistent with demyelination, and sometimes temporal dispersion or partial conduction block. These patterns help distinguish CMT1C from purely axonal neuropathies.SciSpace+2Taylor & Francis Online+2

17. Electromyography (EMG)
    EMG uses a fine needle in muscles to measure electrical activity. In CMT1C, EMG can show signs of chronic denervation and re-innervation (long-standing nerve damage), but usually no active muscle disease. EMG supports the diagnosis and excludes conditions like myopathy or motor neuron disease.NCBI+1

18. F-waves and conduction block analysis
    Special parts of nerve conduction testing look at long-loop responses (F-waves) and check for segments with very slow or blocked conduction. In CMT1C, some studies describe temporal dispersion and partial conduction blocks, which help distinguish it from other neuropathies and guide which gene to test.SciSpace+1

Imaging tests

19. Peripheral nerve ultrasound
    High-resolution ultrasound can measure the cross-sectional area of nerves in the arms and legs. In some CMT1C patients, nerve ultrasound shows mild to moderate nerve enlargement, reflecting chronic demyelinating neuropathy. This non-invasive test can support the diagnosis in expert hands.MalaCards+1

20. MRI to rule out other causes
    Magnetic resonance imaging (MRI) of the spine or brain is usually normal in CMT1C but can be done to exclude spinal cord disease, brain lesions, or nerve root compression that might mimic neuropathy. A normal MRI, together with typical clinical and electrodiagnostic findings, supports the diagnosis of inherited CMT.orpha.net+1

Goals of Treatment in CMT1 with LITAF Mutation

Because this form of CMT is genetic, doctors aim to manage symptoms, keep you as active and independent as possible, and prevent long-term complications such as severe foot deformity, falls, contractures, and chronic pain rather than “fix” the gene. Treatment usually combines non-drug therapies (like physiotherapy, braces, and lifestyle adjustments) with careful use of medicines for neuropathic pain and muscle problems. Surgery and experimental treatments may be considered in selected cases. Care in a neuromuscular clinic, with a team including neurologists, physiotherapists, orthotists, occupational therapists, and genetic counsellors, gives the best long-term results and helps tailor the plan to the exact mutation and severity. ScienceDirect+4PMC+4Physiopedia+4

---

Non-Pharmacological Treatments

Please note: to stay close to your word limit, each item is a bit under 100 words, but still detailed, practical, and SEO-friendly.

1. Physiotherapy-based strengthening exercises
   Regular physiotherapy uses gentle resistance and body-weight exercises to strengthen the remaining healthy muscle fibres in the feet, ankles, legs, and hands. Stronger muscles help support weak joints, improve balance, and slow down loss of function. A therapist designs a safe program that avoids over-fatigue, which can worsen weakness in CMT. Done consistently several times a week, strengthening therapy improves walking speed, reduces falls, and makes daily activities like climbing stairs or using utensils easier over time. PMC+2Physiopedia+2

2. Stretching and contracture prevention
   Daily stretching of ankles, calves, hamstrings, and hand muscles keeps joints flexible and helps prevent contractures, where muscles and tendons become permanently tight. Gentle, sustained stretches held for 20–30 seconds several times a day reduce stiffness and pain and make braces and shoes more comfortable. Physiotherapists often teach a home stretching routine and may use splints at night to hold joints in better positions. This simple routine can delay deformities and keep walking and hand function easier for longer in CMT1. PMC+2Physiopedia+2

3. Aerobic and endurance training
   Light aerobic activities like walking, cycling, or swimming are often recommended to improve heart fitness, stamina, and mood. Low-impact endurance training increases oxygen delivery to muscles and can reduce fatigue during everyday tasks. In CMT, sessions are usually short and frequent, at a comfortable pace, to avoid over-work weakness. Over time, aerobic exercise helps maintain a healthy weight, reduces stress, and supports overall nerve and muscle health, making it easier to stay active despite progressive neuropathy. PMC+2Physiopedia+2

4. Balance and gait training
   Balance exercises, such as standing on different surfaces, weight shifts, and walking drills, help the brain and remaining nerves adapt to weak muscles and numb feet. Therapists may use parallel bars or harness systems to train safe walking patterns and teach strategies like wider stance and slower turns. Improved balance reduces the risk of falls and ankle sprains, which are common in people with CMT due to foot drop and poor sensation. Consistent training can significantly improve confidence in walking. Physiopedia+2PMC+2

5. Ankle-foot orthoses (AFOs)
   AFOs are lightweight plastic or carbon-fiber braces that support the ankle and foot. They lift the toes to correct foot drop and prevent tripping, while stabilizing weak ankle muscles. Custom-fitted AFOs can improve walking efficiency, reduce energy use, and decrease pain. The right brace should feel like an extension of the leg, not a burden, and is adjusted as the disease changes. Regular review by an orthotist ensures the brace still fits and prevents skin pressure sores. ResearchGate+3Charcot-Marie-Tooth Association+3The Foundation for Peripheral Neuropathy+3

6. Custom footwear and insoles
   Special shoes with firm heel counters, wide toe boxes, and cushioned soles help stabilise the foot and reduce pressure on bony prominences and high arches. Custom insoles or inserts can correct mild deformities, redistribute weight, and improve comfort in people with pes cavus and claw toes. Good footwear reduces calluses, ulcers, and pain, making longer walks and daily standing tasks easier. A podiatrist or orthotist usually chooses designs based on foot shape and walking style. The Foundation for Peripheral Neuropathy+2www.slideshare.net+2

7. Occupational therapy for hand and daily tasks
   Occupational therapists focus on hand function and everyday activities, such as writing, typing, dressing, and cooking, which can become difficult when grip is weak and sensation is reduced. They may recommend hand exercises, adaptive tools with larger handles, button hooks, and energy-saving techniques. These strategies allow people with CMT1 to keep working, studying, and managing self-care independently for longer, despite progressive nerve damage in the hands and fingers. PMC+1

8. Assistive walking devices
   Canes, crutches, or walkers can be important when weakness and balance problems increase. These devices widen the base of support, reduce load on weak ankles and knees, and lower the risk of falls. Proper fitting and training are essential so the device improves safety without causing shoulder or wrist strain. Using an assistive device is not a “failure”; it is a tool to keep people with CMT active and independent in the community. PMC+1

9. Pain coping and cognitive-behavioural therapy (CBT)
   Chronic neuropathic pain and fatigue can cause stress, anxiety, and low mood. CBT and other psychological therapies teach coping skills, pacing strategies, relaxation, and ways to handle negative thoughts about disability. These approaches do not remove nerve damage but can reduce pain intensity, improve sleep, and make it easier to follow physiotherapy and exercise plans. Combining mental-health support with physical care often improves overall quality of life in long-term neurological conditions, including CMT. PMC+2PMC+2

10. Education and genetic counselling
    Because CMT1C is autosomal dominant, there is a 50% chance of passing the mutation to children. Genetic counselling explains inheritance, testing options for family members, and reproductive choices such as pre-implantation genetic diagnosis. Education about the disease course, realistic expectations, and early signs of complications helps families plan ahead and seek help promptly. Understanding the role of the LITAF gene also prepares patients for future gene-based therapies as research advances. ScienceDirect+3PMC+3PLOS+3

11. Workplace and school adaptations
    Occupational therapists and social workers can recommend adjustments such as shorter walking distances, ergonomic chairs, footrests, adapted keyboards, and flexible schedules. These changes reduce fatigue and pain and lower the risk of falls in corridors or stairways. Simple modifications help students and workers with CMT keep up with their peers and maintain productivity without worsening their neuropathy. Early planning is especially important during school transitions and new job roles. PMC+1

12. Home safety modifications
    Home changes like grab rails in bathrooms, non-slip mats, adequate lighting, and removal of loose rugs can cut fall risk dramatically. Ramps or stair rails may be needed if ankle weakness and foot drop are severe. An occupational therapist can perform a home assessment and suggest cost-effective improvements. These steps are crucial because fractures or head injuries from falls can lead to sudden loss of independence in people with CMT1. PMC+1

13. Energy conservation and pacing
    Fatigue is a common symptom in CMT because weak muscles have to work harder to perform basic tasks. Learning to pace activities, take planned rest breaks, and prioritise important tasks helps manage limited energy. Therapists might suggest sitting for chores that usually require standing, breaking jobs into smaller parts, and using devices like trolleys to move items. These strategies allow people to do more across the day without worsening pain or weakness. PMC+1

14. Weight management and healthy lifestyle
    Maintaining a healthy body weight reduces load on weak ankles, knees, and hips and makes braces and walking aids more effective. Balanced eating and regular low-impact activity also support heart health and blood sugar control, which are important because diabetes and obesity can worsen neuropathy. Avoiding smoking and limiting alcohol helps protect remaining nerve function. Lifestyle changes are simple but powerful long-term tools in managing hereditary neuropathies. EBSCO+1

15. Joint protection and ergonomic training
    Because muscles are weak, joints like the ankles, knees, and wrists can be overloaded and develop pain or early arthritis. Joint protection techniques include using both hands for heavy objects, avoiding deep squatting, and using tools with better leverage. Ergonomic advice for sitting, standing, and lifting helps keep joint angles safer. This approach preserves function and reduces additional musculoskeletal problems on top of the neuropathy. PMC+1

16. Hydrotherapy and water-based exercise
    Exercising in warm water reduces stress on joints and makes movement easier for weak muscles. Pool therapy can include walking, gentle jumping, and stretching supported by buoyancy. It is often less painful and more enjoyable than land-based exercises, encouraging long-term adherence. Hydrotherapy can improve cardiovascular fitness, flexibility, and mood, especially in people who struggle with traditional gym activities due to CMT-related pain or balance problems. PMC+2PMC+2

17. Massage and soft-tissue techniques
    Massage and soft-tissue mobilisation can help relieve muscle tightness, reduce discomfort around braces, and improve circulation in weaker limbs. While massage does not change the underlying nerve damage, many people report temporary relief from pain and stiffness and improved sense of wellbeing. It should be done carefully to avoid pressure damage in areas of reduced sensation and is best guided by professionals familiar with neurological conditions. PMC+1

18. Transcutaneous electrical nerve stimulation (TENS)
    TENS uses small electrical currents delivered through skin pads to reduce pain signals going to the brain. In some people with neuropathic pain, it provides short-term relief and allows lower doses of pain medicines. The device settings are usually adjusted by a therapist, and patients are taught safe home use. TENS is not a cure, and it does not work for everyone, but it is a low-risk non-drug option worth considering in chronic neuropathy pain management. PMC+2PMC+2

19. Peer support and patient organisations
    Connecting with CMT support groups and organisations gives emotional support, practical tips, and information about new research and clinical trials. Hearing others’ experiences can reduce feelings of isolation and help people understand realistic expectations for living with CMT1C. Support organisations also advocate for accessibility and research funding that may eventually lead to gene-targeted treatments for LITAF-related neuropathy. CMT Research Foundation+2EBSCO+2

20. Participation in clinical research (carefully supervised)
    Some patients may choose to join observational studies or early-phase clinical trials that test new drugs, gene therapies, or regenerative treatments. These studies follow strict safety rules and may offer access to experimental therapies, but they also carry unknown risks and are not guaranteed to help. Decisions should always be made with experienced neurologists and family members, with clear understanding of benefits and limitations. ScienceDirect+2CMT Research Foundation+2

---

Drug Treatments

Important: There are no FDA-approved medicines that specifically cure or reverse CMT1 due to LITAF mutation. The drugs below are commonly used to treat symptoms like neuropathic pain, muscle cramps, mood, and sleep, based on their approved use for other neuropathic or pain conditions. Doses are general; any actual prescription must be personalised by a doctor.

1. Pregabalin (Lyrica)
   Pregabalin is an anti-seizure medicine approved for several neuropathic pain conditions, including diabetic peripheral neuropathy and post-herpetic neuralgia. It binds to calcium channels in nerve cells and reduces the release of pain-signalling chemicals, which can ease burning and shooting pains in feet and hands. Typical adult doses for neuropathic pain range from about 150–600 mg per day split into two or three doses, adjusted for kidney function and side effects like dizziness, sleepiness, and weight gain. NCBI+5FDA Access Data+5FDA Access Data+5

2. Duloxetine (Cymbalta and related duloxetine products)
   Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant that is FDA-approved for neuropathic pain from diabetic neuropathy, fibromyalgia, chronic musculoskeletal pain, and depression and anxiety. It increases levels of serotonin and noradrenaline in pain pathways, which can reduce neuropathic pain intensity. Doses for neuropathic pain are often around 60–120 mg daily. Common side effects include nausea, dry mouth, sleepiness, sweating, and constipation, and it must be used carefully in people with liver disease or high blood pressure. FDA Access Data+4FDA Access Data+4FDA Access Data+4

3. Gabapentin (Neurontin, Gralise, Horizant)
   Gabapentin is another anti-seizure drug widely used for neuropathic pain, including post-herpetic neuralgia. It reduces abnormal firing in damaged nerves by acting on calcium channels. For neuropathic pain, doses may be slowly increased up to about 1800–3600 mg per day, divided into several doses, or given as extended-release forms. Side effects can include dizziness, tiredness, swelling in the legs, and weight gain. Dose changes should be gradual to avoid withdrawal symptoms or rebound pain. FDA Access Data+3FDA Access Data+3FDA Access Data+3

4. Amitriptyline (tricyclic antidepressant)
   Amitriptyline is an older antidepressant that is commonly used in low doses to treat neuropathic pain and improve sleep. It blocks reuptake of serotonin and noradrenaline and has additional effects on pain-modulating receptors. For nerve pain, doses are often much lower than depression doses, for example starting at 10–25 mg at night and increasing slowly. Side effects include dry mouth, constipation, drowsiness, weight gain, and, rarely, heart rhythm problems, so careful monitoring is needed, especially in older or heart-sick patients. FDA Access Data+4PMC+4DrugBank+4

5. Nortriptyline (tricyclic antidepressant)
   Nortriptyline is related to amitriptyline but may cause fewer sedating and anticholinergic side effects in some people. It is often used when amitriptyline is not tolerated. It works in a similar way by boosting serotonin and noradrenaline in pain pathways. Low doses at night can ease neuropathic pain and improve sleep. Side effects may include dry mouth, constipation, dizziness, and changes in heart rhythm, and it should be started and adjusted only under medical supervision with ECG monitoring if needed. PMC+2DrugBank+2

6. Venlafaxine (SNRI antidepressant)
   Venlafaxine is another SNRI that can help with neuropathic pain, anxiety, and depression in chronic neurological diseases. It increases serotonin and noradrenaline activity, similar to duloxetine, and may reduce pain perception. Doses are usually slowly increased from low starting levels. Side effects include increased blood pressure, nausea, sweating, and sleep changes. It must not be stopped suddenly because that can cause withdrawal symptoms, so any dose change should be planned with a doctor. PMC+2FDA Access Data+2

7. Tramadol (Ultram, Conzip and generics)
   Tramadol is a weak opioid pain medicine that also affects serotonin and noradrenaline reuptake, making it useful in some cases of moderate neuropathic or musculoskeletal pain. It is reserved for people who do not respond to safer options and is used at the lowest effective dose for the shortest time because it carries risks of dependence, breathing depression, and seizures. Typical adult dosing is carefully titrated by doctors, and combining tramadol with other serotonin-acting drugs can raise the risk of serotonin syndrome. FDA Access Data+4FDA Access Data+4FDA Access Data+4

8. Topical lidocaine patches or gels
   Lidocaine patches applied to painful areas on the feet or legs numb the skin and underlying nerves without affecting the whole body. They can be useful for localised burning or shooting pains and often cause fewer systemic side effects than oral drugs. The patch is usually worn for a limited number of hours each day. Skin irritation or rash can occur, and they should not be applied to broken or infected skin. PMC+2EBSCO+2

9. Topical capsaicin creams or patches
   Capsaicin, the active component of chilli peppers, can reduce pain by depleting substance P and temporarily desensitising pain nerve endings in the skin. Low-strength creams are applied several times a day, while high-dose patches are used under specialist supervision. Burning and redness are common at the start but may reduce over time. Capsaicin is another option for localised neuropathic pain that may allow lower doses of systemic medicines. EBSCO+1

10. Non-steroidal anti-inflammatory drugs (NSAIDs)
    NSAIDs such as ibuprofen or naproxen mainly help with muscle and joint pain, not pure nerve pain, but they can be useful when foot deformities or abnormal gait cause secondary mechanical pain. They work by blocking cyclo-oxygenase enzymes involved in inflammation. Because NSAIDs can irritate the stomach and affect kidneys and blood pressure, they should be used at the lowest effective dose and avoided long-term in high-risk patients. PMC+1

11. Paracetamol (acetaminophen)
    Paracetamol can be used for mild pain or combined with other medicines for stronger pain relief. It does not treat nerve damage but can help reduce general discomfort and fever. It is usually well tolerated at recommended total daily doses, but high doses or use in liver disease can cause serious liver injury, so maximum daily limits must always be respected. PMC+1

12. Baclofen (oral or intrathecal)
    Baclofen is a GABA-B agonist used to treat spasticity in conditions such as multiple sclerosis and spinal cord disease. In some people with CMT who also have muscle stiffness or cramps, low doses may help relax muscles and reduce spasms. It acts on the spinal cord to decrease over-active reflexes. Common side effects include drowsiness, dizziness, and weakness, and sudden withdrawal can cause serious reactions, so it must be tapered carefully. Intrathecal baclofen pumps are usually reserved for severe spasticity in other conditions. FDA Access Data+3FDA Access Data+3FDA Access Data+3

13. Magnesium supplements or medicines for cramps (under supervision)
    Some doctors may recommend magnesium or other agents in people with muscle cramps, though the evidence is modest. Magnesium is involved in muscle relaxation and nerve conduction. Doses must be adjusted for kidney function, and diarrhoea or stomach upset can occur. Because cramps in CMT mostly reflect nerve damage, these treatments are supportive and should not give false hope of nerve repair, but they may reduce discomfort in some individuals. nhs.uk+1

14. Short-term benzodiazepines for severe anxiety or spasms
    Very short-term use of medicines like clonazepam or diazepam may be considered for severe sleep-disturbing cramps or anxiety in carefully selected patients. They enhance GABA activity in the brain and spinal cord, promoting relaxation. However, they carry high risks of dependence, drowsiness, falls, and breathing problems, especially when combined with opioids. For this reason, they should be used only under strict medical supervision and usually for limited periods. PMC+1

15. Selective serotonin reuptake inhibitors (SSRIs) for mood
    Medicines like sertraline or fluoxetine may not directly reduce nerve pain but can treat depression and anxiety associated with chronic CMT symptoms. Better mental health can lower perceived pain levels and improve engagement with physiotherapy. SSRIs adjust serotonin levels in the brain and have side effects such as stomach upset, sleep changes, and, rarely, bleeding problems. They should be monitored by a doctor, especially when combined with other serotonin-active drugs. EBSCO+1

16. Sleep-aid medicines (used sparingly)
    In some cases, low-dose sedating antidepressants or other sleep medicines are used for short periods when neuropathic pain severely disrupts sleep. Good sleep hygiene and non-drug methods are tried first, because long-term sleeping pills can cause dependence and morning drowsiness. Adequate sleep is vital for coping with chronic pain and fatigue in CMT. Any pharmacological sleep aid must be selected individually and reviewed often. PMC+1

17. Vitamin B12 replacement in deficiency
    If someone with CMT also has vitamin B12 deficiency, treating it is essential, because B12 deficiency itself can damage nerves and worsen neuropathy. B12 may be given as tablets or injections depending on absorption. It helps in myelin synthesis and nerve repair. Correcting deficiency can improve numbness and balance, though it will not fix genetic CMT1, it can prevent additional avoidable nerve injury. The Times of India+5Cleveland Clinic+5PubMed+5

18. Alpha-lipoic acid (prescribed in some regions as a medicine)
    Alpha-lipoic acid is an antioxidant used as a drug for diabetic peripheral neuropathy in some countries and as a supplement elsewhere. Studies show it can improve neuropathy symptoms by reducing oxidative stress and improving blood flow in nerves. It is not specific to CMT but may be considered in selected cases under specialist advice. Side effects can include nausea and skin rash, and doses vary between oral and intravenous forms. American Academy of Neurology+5PubMed+5MDPI+5

19. Coenzyme Q10 in mitochondrial involvement or deficiency
    In rare situations where CMT is complicated by mitochondrial problems or documented CoQ10 deficiency, coenzyme Q10 may be tried to support energy production in nerve cells. It is better established in mitochondrial diseases but is sometimes used off-label in neuropathies. Evidence is mixed, and benefits are usually modest. It is generally well tolerated but can cause stomach upset. Any use should be guided by specialists after careful evaluation. Nature+5PMC+5ClinicalTrials+5

20. Other emerging neuropathic pain and neuroprotective agents
    Research in demyelinating CMT is exploring new small molecules, gene-based therapies, and neuroprotective drugs that target myelin biology, inflammation, or ion channels in nerves. While some show promise in animal models and early human studies, none are yet established standard treatment for CMT1C caused by LITAF mutation. Patients should discuss clinical trial options with specialist centres, understanding that these treatments remain experimental. PMC+3ScienceDirect+3CMT Research Foundation+3

---

Dietary Molecular Supplements

Supplements do not replace medical care and have limited direct evidence in CMT, but some may support general nerve health or correct deficiencies.

1. Vitamin B12 – Supports myelin formation and nerve repair; deficiency can cause neuropathy. Typical supplemental doses vary from a few micrograms in multivitamins to much higher doses or injections when deficiency is diagnosed. It may reduce tingling and improve balance if low B12 is present but will not cure genetic CMT. The Times of India+5Cleveland Clinic+5PubMed+5

2. Alpha-lipoic acid – A powerful antioxidant studied in diabetic neuropathy. Doses often range from about 300–600 mg daily in trials. It is thought to work by reducing oxidative stress and improving blood flow within nerves. Some people report reduced burning pain and improved symptoms, but long-term benefit in CMT specifically is unproven. American Academy of Neurology+5PubMed+5MDPI+5

3. Omega-3 fatty acids (EPA and DHA) – Omega-3s from fish oil or algae are important for nerve membranes. Animal and early human studies suggest they may help nerve regeneration and reduce neuropathic pain, though high-quality data in inherited neuropathy are limited. Typical supplemental doses vary from 500 mg to several grams per day. They may thin the blood slightly, so medical advice is needed if on anticoagulants. Omegor.com+5PMC+5Dove Medical Press+5

4. Vitamin D – Important for bone health, muscle function, and immune regulation. Many people with chronic illness have low vitamin D, which can worsen muscle weakness and fracture risk. Supplement doses depend on blood levels and local guidelines. Correcting deficiency supports bone strength in people with foot deformities or balance issues, though its direct effect on CMT neuropathy is uncertain. nhs.uk+1

5. B-complex vitamins (B1, B6, B9) – B vitamins support nerve metabolism. Correcting deficiencies in thiamine (B1) or pyridoxine (B6) can prevent additional neuropathic damage. However, excessive B6 can itself cause neuropathy, so supplement doses must remain within safe limits. A balanced B-complex under medical supervision may help overall nerve health where diet is poor. nhs.uk+3Cleveland Clinic+3PubMed+3

6. Coenzyme Q10 – As above, CoQ10 supports mitochondrial energy production. Doses commonly range from 100–300 mg daily in supplements. It is mainly studied in mitochondrial and heart conditions, with mixed results, and its role in CMT1C is uncertain. It may be considered in selected cases, especially if there is evidence of mitochondrial dysfunction or deficiency. Nature+4PMC+4ScienceDirect+4

7. Curcumin (from turmeric) – Curcumin has anti-inflammatory and antioxidant properties. Experimental studies suggest it may modulate cell signalling and oxidative stress, but direct data in hereditary neuropathies are limited. It is often used in doses of several hundred milligrams per day, sometimes with piperine to improve absorption. It may cause stomach upset and interact with blood thinners, so medical advice is important. MDPI+2MDPI+2

8. Resveratrol – A plant compound with antioxidant and potential neuroprotective actions, studied mainly in animals and early human trials. It may influence mitochondrial function and inflammation, but there is no strong evidence for use in CMT. If used, it should be at standard supplement doses and discussed with a doctor because of possible interactions. PMC+2ScienceDirect+2

9. Magnesium – Supports muscle relaxation and nerve conduction. Supplementation can help in deficiency or in some people with cramps, but high doses may cause diarrhoea and should be avoided in severe kidney disease. It is best obtained from diet (nuts, seeds, legumes, green vegetables) with supplements only when needed. nhs.uk+2MDPI+2

10. General multivitamins (correcting overall deficiency)
    A standard multivitamin can correct mild combined deficiencies in people with poor diet or absorption problems. While it will not reverse genetic CMT, avoiding deficiencies in B vitamins, vitamin D, and other nutrients is an important part of protecting overall nerve and muscle health. It should be used as a safety net, not as a replacement for healthy eating. The Times of India+3Cleveland Clinic+3nhs.uk+3

---

Regenerative, Immunity-Boosting and Stem-Cell-Related Drugs

For CMT1 due to LITAF mutation, regenerative and stem-cell therapies are still experimental. None are established standard care; most are studied only in animals or early human trials.

1. Experimental gene therapy targeting LITAF
   Future strategies may involve delivering a correct copy of the LITAF gene to Schwann cells (myelin-producing cells) using viral vectors. The goal is to restore proper LITAF function, improve myelin stability, and slow or stop nerve damage. Safety issues include immune reactions, off-target effects, and long-term expression. At present, such therapies are in pre-clinical or very early research, not routine treatment, but they represent a promising direction for disease-modifying CMT care. CMT Research Foundation+3PLOS+3PMC+3

2. Gene-silencing or editing approaches (general demyelinating CMT research)
   Some research in demyelinating CMT explores silencing harmful gene products or editing mutations using technologies like antisense oligonucleotides or CRISPR-based tools. For LITAF-related CMT1, future approaches may aim to correct or reduce mutant protein that misfolds and disrupts myelin. These approaches are complex and carry risks of immune reactions and off-target gene changes, so they are currently limited to experimental models and clinical-trial settings. ScienceDirect+2PLOS+2

3. Autologous mesenchymal stem-cell therapy (experimental)
   Studies in other neuropathies have looked at using a patient’s own bone-marrow or fat-derived mesenchymal stem cells to release growth factors that support nerve repair and myelin health. These cells may modulate inflammation and secrete neurotrophic factors, but robust evidence in hereditary CMT is lacking. Such treatments are not approved for CMT and should only be considered within well-regulated clinical trials, because unregulated “stem-cell clinics” can be unsafe and very costly. ScienceDirect+1

4. Neurotrophic growth-factor therapies
   Neurotrophins and related growth factors can promote nerve survival and remyelination in animal models of neuropathy. Some compounds are being investigated as injections or gene therapies to deliver growth factors directly to peripheral nerves. However, early human trials have often been limited by side effects, short duration of benefit, or difficulty targeting nerves precisely. For now, these options remain experimental and are not standard treatment for CMT1C. ScienceDirect+2PMC+2

5. Immunomodulatory approaches in misdiagnosed or overlapping cases
   Occasionally, CMT1C can be confused with acquired demyelinating neuropathies that respond to immune treatments like intravenous immunoglobulin (IVIG) or steroids. Once a clear genetic diagnosis of LITAF-related CMT is confirmed, routine immune-suppressing treatment is usually not helpful. Immune drugs may be considered only if there is evidence of overlapping autoimmune neuropathy. This underlines the importance of accurate diagnosis before starting strong immunotherapy. ScienceDirect+3Charcot-Marie-Tooth News+3PPM+3

6. CoQ10-related and mitochondrial-targeting molecules (very early stage)
   New molecules that improve mitochondrial function or act as precursors to CoQ10 are being studied in other genetic neurological diseases and may one day be relevant to neuropathies with mitochondrial involvement. Animal and early human reports show some improvement in neurological symptoms, but they are not yet studied in LITAF-related CMT. These drugs highlight the potential of targeting cellular energy pathways in future regenerative strategies. Nature+4PMC+4MDPI+4

---

Surgical Options (Procedures and Why They Are Done)

1. Foot deformity correction (osteotomy and soft-tissue balancing)
   In many people with CMT1, high-arched feet, claw toes, and ankle instability develop over time. Orthopaedic surgeons may perform osteotomies (bone cuts) and tendon transfers to rebalance the foot and improve alignment. The goal is to create a more plantigrade (flat and stable) foot that fits better in shoes or braces, reducing pain, calluses, and risk of ankle sprains and falls. EBSCO+3PMC+3www.slideshare.net+3

2. Tendon transfer surgery
   Tendon transfers move tendons from stronger muscles to take over the function of very weak ones, such as muscles that lift the toes. This can improve foot clearance during walking and reduce tripping. The procedure is tailored to the individual pattern of weakness and typically combined with other foot corrections. Tendon transfers do not cure neuropathy but can significantly improve gait mechanics when carefully planned. EBSCO+3PMC+3The Foundation for Peripheral Neuropathy+3

3. Arthrodesis (joint fusion)
   In severe deformity, joint fusion surgery may be used to stabilise a very unstable or painful joint, such as the ankle or midfoot. The bones are fixed together with screws or plates so the joint no longer moves. This sacrifices flexibility but can provide a much more stable and pain-free base for standing and walking and can make bracing more effective. It is usually considered after other options fail. PMC+1

4. Spinal surgery for scoliosis
   Some people with CMT develop curvature of the spine (scoliosis) due to muscle imbalance. If the curve is severe and causes pain, breathing problems, or cosmetic concerns, spinal fusion surgery may be recommended. This involves straightening and stabilising the spine with rods and screws. The aim is to prevent further curvature and protect lung function, especially in young people still growing. PMC+1

5. Nerve decompression in selected cases
   Occasionally, people with CMT may also have compressive nerve problems, such as carpal tunnel syndrome. Surgical decompression of the nerve at the wrist or other narrow passages can relieve additional pressure and improve symptoms like hand numbness or weakness. This does not correct the underlying CMT but treats an extra problem that is making nerve function worse. Careful testing is needed to decide if decompression will help. EBSCO+2Cureus+2

---

Prevention Strategies

1. You cannot prevent the genetic mutation, but early diagnosis allows timely physiotherapy, orthotics, and lifestyle changes that delay complications. PMC+3PMC+3PPM+3

2. Avoid smoking, which damages blood vessels and nerves and can worsen neuropathy and wound healing. nhs.uk+1

3. Limit alcohol, as heavy use can directly injure nerves and add to neuropathy. nhs.uk+1

4. Maintain a healthy body weight to reduce strain on weak ankles and feet and lower risk of diabetes, which can cause additional neuropathy. nhs.uk+1

5. Protect your feet with well-fitting shoes, daily skin checks, and prompt treatment of blisters or ulcers to avoid infections and deformities. EBSCO+2The Foundation for Peripheral Neuropathy+2

6. Prevent falls by using braces or walking aids when recommended and by making home safety changes such as grab rails and good lighting. PMC+1

7. Treat vitamin deficiencies, especially vitamin B12 and vitamin D, to avoid extra nerve and bone problems. The Times of India+5Cleveland Clinic+5PubMed+5

8. Manage other illnesses, like diabetes or thyroid disease, that can worsen neuropathy. Regular check-ups help catch problems early. nhs.uk+2Cleveland Clinic+2

9. Avoid toxic medicines when possible, such as certain chemotherapy or high-dose B6 supplements that can damage nerves, and always discuss risks with your doctor. nhs.uk+2ScienceDirect+2

10. Family planning and genetic counselling help relatives understand their risk and consider options such as pre-implantation genetic testing to reduce passing on the mutation. ScienceDirect+3PMC+3PLOS+3

---

What to Eat and What to Avoid

1. Eat a balanced diet rich in vegetables, fruits, whole grains, and lean proteins to provide vitamins, minerals, and antioxidants that support general nerve and muscle health. nhs.uk+2Cleveland Clinic+2

2. Include sources of omega-3 fatty acids, such as oily fish, flaxseeds, chia seeds, or algae-based supplements, which may support nerve membranes and reduce inflammation, although evidence in CMT is limited. MDPI+3PMC+3Dove Medical Press+3

3. Ensure enough B12, mainly from animal foods like meat, fish, eggs, and dairy, or fortified foods and supplements if you are vegetarian or have absorption problems, to prevent additional neuropathy. The Times of India+3Cleveland Clinic+3Verywell Health+3

4. Choose calcium and vitamin-D-rich foods (dairy, fortified plant milks, leafy greens) to support bone strength in feet and spine, especially if mobility is reduced. nhs.uk+1

5. Avoid very high sugar intake and ultra-processed foods that promote obesity and diabetes, which can cause extra nerve damage on top of CMT. nhs.uk+1

6. Limit saturated and trans fats, choosing healthier fats (olive oil, nuts, seeds) to protect heart and blood vessels that supply nerves. nhs.uk+2PMC+2

7. Stay well hydrated with water and limit sugary drinks and excessive caffeine, which can worsen sleep and, in some people, muscle cramps. nhs.uk+1

8. Avoid excessive alcohol, which can directly damage nerves and worsen balance problems. nhs.uk+1

9. Be cautious with “mega-doses” of supplements, especially B6 and unregulated herbal products, which can sometimes harm nerves or interact with medicines. FDA Access Data+3ScienceDirect+3Cleveland Clinic+3

10. Work with a dietitian if you have weight problems, food restrictions, or other medical conditions; they can create a personalised plan that supports nerve health and is realistic for your lifestyle. nhs.uk+2Cleveland Clinic+2

---

When to See a Doctor

You should see a doctor (ideally a neurologist with experience in neuromuscular diseases) if you notice new or worsening symptoms, such as increasing foot drop, more frequent falls, new hand weakness, or severe pain that is not controlled by simple measures. Sudden changes, such as rapid loss of strength, new numbness in a different pattern, or bladder and bowel problems, need urgent evaluation to make sure there is not another treatable condition on top of CMT. If you develop sores on your feet that do not heal, severe back pain with scoliosis, or major mood changes or thoughts of harming yourself, medical help should be sought right away. Genetic counselling visits are also important when planning a family or if relatives need testing advice. EBSCO+4Cureus+4PPM+4

Because you are a teenager, it is especially important to involve your parents or guardians and your healthcare team in all decisions about medicines, supplements, or experimental treatments, and never start or stop prescribed drugs on your own.

---

FAQs About CMT1 Due to LITAF Mutation

1. Is there a cure for Charcot-Marie-Tooth disease type 1 caused by LITAF mutation?
   No. At present there is no cure or disease-modifying drug that can fix the LITAF gene or completely stop CMT1C. Treatment focuses on physiotherapy, braces, pain control, surgery when needed, and avoiding extra nerve damage while research explores gene-based and regenerative therapies. PLOS+3CMT Research Foundation+3ScienceDirect+3

2. Will I end up in a wheelchair?
   Many people with CMT1C remain able to walk with braces or aids for many years, although weakness usually slowly worsens. The likelihood of needing a wheelchair depends on how severe the mutation is, how early treatment starts, and other health factors. Early physiotherapy and orthotic care help preserve mobility. EBSCO+3PMC+3PPM+3

3. Can exercise make my nerves worse?
   Over-strenuous exercise can temporarily worsen weakness, but well-planned, low-impact strengthening and aerobic programs designed by a physiotherapist are safe and beneficial. The key is pacing, avoiding heavy weights, and stopping when muscles are very tired or painful. PMC+2Physiopedia+2

4. Is CMT1C always inherited from a parent?
   Most cases are autosomal dominant and inherited from an affected parent, but sometimes a new mutation appears for the first time in a family. Genetic testing and counselling can clarify the pattern and help relatives understand their own risks. PMC+2PLOS+2

5. Can diet cure CMT?
   No diet can cure the genetic cause of CMT1C. However, healthy eating, correcting vitamin deficiencies, and maintaining a healthy weight can support overall nerve and muscle health and prevent extra problems like diabetes or osteoporosis, which can worsen disability. EBSCO+3nhs.uk+3Cleveland Clinic+3

6. Are pain medicines like pregabalin or duloxetine safe to use long term?
   They can be used long term under medical supervision, but they have side effects such as dizziness, sleepiness, weight gain, or stomach and mood changes, so regular review is needed. Doctors usually start with low doses and adjust slowly to balance benefits and risks. FDA Access Data+4FDA Access Data+4NCBI+4

7. Should I try stem-cell therapy offered by private clinics?
   Be very cautious. Most stem-cell treatments for CMT are unproven, expensive, and may be unsafe. At present, stem-cell and gene therapies should only be received inside regulated clinical trials at reputable research centres, not in commercial “miracle cure” clinics. ScienceDirect+3ScienceDirect+3CMT Research Foundation+3

8. Can CMT be confused with other nerve diseases?
   Yes. Before genetic testing, some people with CMT1C were misdiagnosed as having inflammatory demyelinating neuropathies. Nerve conduction studies, family history, and genetic tests help distinguish them, because treatment options differ. PMC+3Cureus+3Charcot-Marie-Tooth News+3

9. Is pregnancy safe if I have CMT1C?
   Many women with CMT have healthy pregnancies and babies. Symptoms like balance issues or fatigue may worsen temporarily. Genetic counselling is important to discuss the 50% chance of passing on the mutation and the options available. Obstetric and neurology teams should plan care together. PMC+2PLOS+2

10. Can children with CMT play sports?
    With appropriate braces, shoe wear, and supervision, many children with CMT can take part in low-impact sports and physical activities. Contact sports or high-risk activities that increase the chance of ankle injuries or falls may need to be adapted or avoided. A paediatric neurologist and physiotherapist can give tailored advice. EBSCO+3The Foundation for Peripheral Neuropathy+3www.slideshare.net+3

11. Why are my feet so high-arched and my toes clawed?
    Selective weakness of some foot muscles and relative strength of others, due to motor nerve damage, pulls the foot into a high arch and the toes into claw positions. Over time, tight tendons and ligaments fix these deformities, sometimes needing surgery or bracing. www.slideshare.net+4Cureus+4PPM+4

12. Do vitamins and supplements actually help my nerves?
    Supplements like B12, alpha-lipoic acid, and omega-3 can help if you have a deficiency or another neuropathy, but strong proof that they change genetic CMT1C is limited. They should be used only with your doctor’s guidance, mainly to fix deficiencies and support overall health. MDPI+6Cleveland Clinic+6PubMed+6

13. Can CMT affect my breathing or heart?
    Some forms of CMT can, rarely, involve respiratory muscles or cause scoliosis that affects lung function. Heart involvement is uncommon but possible in certain genetic types. Regular follow-up and reporting of breathlessness, chest pain, or severe fatigue allow early detection and management of these complications. ScienceDirect+3PMC+3Cureus+3

14. Will research really bring treatments for CMT1C?
    Research on demyelinating CMT, including gene therapy and new drugs, is moving quickly, and patient organisations and foundations are funding LITAF-related studies. While timelines are uncertain, understanding of disease mechanisms is improving, giving realistic hope for targeted treatments in the future. Charcot-Marie-Tooth News+3ScienceDirect+3CMT Research Foundation+3

15. What is the most important thing I can do right now?
    The most helpful steps are: stay in regular contact with a neurologist, follow physiotherapy and stretching programs, use braces and safe footwear as recommended, protect your feet, maintain a healthy lifestyle, and seek emotional and practical support when needed. These actions cannot change your genes but can greatly improve day-to-day life with CMT1 due to LITAF mutation. nhs.uk+4PMC+4Physiopedia+4

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 25, 2025.